Protocol No.: A031704

PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated Renal Cell Cancer (PDIGREE)
Principal Investigator
Kolodney, Joanna
Phase
III
Age Group
Adult
Applicable Disease Site
Genitourinary Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Sabrina Rexroad, RN
Research Nurse
Phone: +1 304-293-6066

View on ClinicalTrials.gov